David Lodge

University of Bristol, Bristol, England, United Kingdom 
"David Lodge"
Mean distance: 16.33 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Frenguelli B, Lodge D, Rammes G, et al. (2021) A tribute to Chris Parsons. Neuropharmacology. 195: 108633
Kang H, Park P, Han M, et al. (2020) (2,6)- and (2,6)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice. Brain and Neuroscience Advances. 4: 2398212820957847
Wallach J, Colestock T, Agramunt J, et al. (2019) Pharmacological characterizations of the legal high fluorolintane and isomers. European Journal of Pharmacology. 172427
Lodge D, Watkins JC, Bortolotto ZA, et al. (2018) The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries. Neurochemical Research
Wood CM, Wafford KA, McCarthy AP, et al. (2018) Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression. Neuropharmacology
Ingram R, Kang H, Lightman S, et al. (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
Mastroiacovo F, Moyanova S, Cannella M, et al. (2017) Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia. Molecular Brain. 10: 39
Collingridge GL, Lee Y, Bortolotto ZA, et al. (2016) Antidepressant Actions of Ketamine Versus Hydroxynorketamine. Biological Psychiatry
Collingridge GL, Lodge D, Mayer M, et al. (2016) Ionotropic glutamate receptors: still exciting after all these years. Neuropharmacology
Kang H, Park P, Bortolotto ZA, et al. (2016) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
See more...